174 related articles for article (PubMed ID: 35551231)
1. Rat prostate tumors induce DNA synthesis in remote organs.
Halin Bergström S; Lundholm M; Nordstrand A; Bergh A
Sci Rep; 2022 May; 12(1):7908. PubMed ID: 35551231
[TBL] [Abstract][Full Text] [Related]
2. Highly aggressive rat prostate tumors rapidly precondition regional lymph nodes for subsequent metastatic growth.
Strömvall K; Lundholm M; Thysell E; Bergh A; Halin Bergström S
PLoS One; 2017; 12(10):e0187086. PubMed ID: 29073272
[TBL] [Abstract][Full Text] [Related]
3. Aggressive rat prostate tumors reprogram the benign parts of the prostate and regional lymph nodes prior to metastasis.
Strömvall K; Thysell E; Halin Bergström S; Bergh A
PLoS One; 2017; 12(5):e0176679. PubMed ID: 28472073
[TBL] [Abstract][Full Text] [Related]
4. Extracellular Vesicles from Metastatic Rat Prostate Tumors Prime the Normal Prostate Tissue to Facilitate Tumor Growth.
Halin Bergström S; Hägglöf C; Thysell E; Bergh A; Wikström P; Lundholm M
Sci Rep; 2016 Aug; 6():31805. PubMed ID: 27550147
[TBL] [Abstract][Full Text] [Related]
5. Reduced number of CD169
Strömvall K; Sundkvist K; Ljungberg B; Halin Bergström S; Bergh A
Prostate; 2017 Nov; 77(15):1468-1477. PubMed ID: 28880401
[TBL] [Abstract][Full Text] [Related]
6. Prostate tumors downregulate microseminoprotein-beta (MSMB) in the surrounding benign prostate epithelium and this response is associated with tumor aggressiveness.
Bergström SH; Järemo H; Nilsson M; Adamo HH; Bergh A
Prostate; 2018 Mar; 78(4):257-265. PubMed ID: 29250809
[TBL] [Abstract][Full Text] [Related]
7. Adaptive (TINT) Changes in the Tumor Bearing Organ Are Related to Prostate Tumor Size and Aggressiveness.
Adamo HH; Strömvall K; Nilsson M; Halin Bergström S; Bergh A
PLoS One; 2015; 10(11):e0141601. PubMed ID: 26536349
[TBL] [Abstract][Full Text] [Related]
8. In vivo expression and function of the sodium iodide symporter following gene transfer in the MATLyLu rat model of metastatic prostate cancer.
La Perle KM; Shen D; Buckwalter TL; Williams B; Haynam A; Hinkle G; Pozderac R; Capen CC; Jhiang SM
Prostate; 2002 Feb; 50(3):170-8. PubMed ID: 11813209
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
Brändström A; Westin P; Bergh A; Cajander S; Damber JE
Cancer Res; 1994 Jul; 54(13):3594-601. PubMed ID: 8012987
[TBL] [Abstract][Full Text] [Related]
11. High-grade tumours promote growth of other less-malignant tumours in the same prostate.
Halin Bergström S; Rudolfsson S; Lundholm M; Josefsson A; Wikström P; Bergh A
J Pathol; 2021 Apr; 253(4):396-403. PubMed ID: 33330991
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor content in metastasizing and nonmetastasizing Dunning prostatic adenocarcinoma.
Häggström S; Bergh A; Damber JE
Prostate; 2000 Sep; 45(1):42-50. PubMed ID: 10960841
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of taxol in rat primary and metastatic prostate tumors: site-dependent pharmacodynamics.
Yen WC; Wientjes MG; Au JL
Pharm Res; 1996 Sep; 13(9):1305-12. PubMed ID: 8893266
[TBL] [Abstract][Full Text] [Related]
14. Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: efficacy of flt3 ligand immunotherapy.
Somers KD; Brown RR; Holterman DA; Yousefieh N; Glass WF; Wright GL; Schellhammer PF; Qian J; Ciavarra RP
Int J Cancer; 2003 Dec; 107(5):773-80. PubMed ID: 14566827
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer induces C/EBPβ expression in surrounding epithelial cells which relates to tumor aggressiveness and patient outcome.
Adamo H; Hammarsten P; Hägglöf C; Dahl Scherdin T; Egevad L; Stattin P; Halin Bergström S; Bergh A
Prostate; 2019 Apr; 79(5):435-445. PubMed ID: 30536410
[TBL] [Abstract][Full Text] [Related]
16. S-phase fraction of human prostate adenocarcinoma studied with in vivo bromodeoxyuridine labeling.
Nemoto R; Hattori K; Uchida K; Shimazui T; Nishijima Y; Koiso K; Harada M
Cancer; 1990 Aug; 66(3):509-14. PubMed ID: 2194646
[TBL] [Abstract][Full Text] [Related]
17. Identification of the rat homologue of KAI1 and its expression in Dunning rat prostate cancers.
Suzuki H; Dong JT; Gao AC; Barrett JC; Isaacs JT
Prostate; 1998 Dec; 37(4):253-60. PubMed ID: 9831222
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS
Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
[TBL] [Abstract][Full Text] [Related]
19. Extratumoral Heme Oxygenase-1 (HO-1) Expressing Macrophages Likely Promote Primary and Metastatic Prostate Tumor Growth.
Halin Bergström S; Nilsson M; Adamo H; Thysell E; Jernberg E; Stattin P; Widmark A; Wikström P; Bergh A
PLoS One; 2016; 11(6):e0157280. PubMed ID: 27280718
[TBL] [Abstract][Full Text] [Related]
20. Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model.
Johannsen M; Thiesen B; Jordan A; Taymoorian K; Gneveckow U; Waldöfner N; Scholz R; Koch M; Lein M; Jung K; Loening SA
Prostate; 2005 Aug; 64(3):283-92. PubMed ID: 15726645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]